Prostate treatment registry aims to find best options for men with BPH

NCT ID NCT07242807

Not yet recruiting Knowledge-focused Sponsor: Necmettin Erbakan University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a large registry that will follow 2,000 men with enlarged prostate (BPH) who receive minimally invasive treatments like Rezum, UroLift, or Aquablation. Researchers will track symptoms, urine flow, and quality of life for up to 6 years to see which treatments work best and for whom. The goal is to provide real-world evidence to guide doctors and patients in choosing the right procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could help doctors choose the best minimally invasive prostate treatment for each patient, improving symptom relief and quality of life.
What could go wrong: This is an observational study, not a treatment trial. It collects data without testing new therapies, so it won't directly lead to a new cure or treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA (BPH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia lower urinary tract obstruction, congenital Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATIC HYPERPLASIA (BPH) LUTS MINIMAL INVASIVE SURGERY

Contacts and locations

Locations

Necmettin Erbakan University Medical Faculty Hospital

Konya, 42250, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.